Evidence-Based Networks Ltd – förlag

A broad and experienced team, including medical oncologists and life scientists, have collaborated to produce this practical guide to cancer immunotherapy. It provides a compendium of best practice, including 23 case studies to act as models for professionals to make decisions, either for individual patients or as the basis for using immunotherapy across an organisation, planning area, region or country. As well as introducing all key concepts, expert practitioners provide a guide to future treatments using novel technologies, discuss key problems and suggest solutions, and consider the costs of immunotherapy treatments.This guide also makes an excellent training tool, which will help new teams and clinical staff to develop procedures, and adopt best practice.This resource is produced in partnership with the Association of Cancer Physicians (ACP).

Increasing attention is being paid to the needs of cancer patients who present acutely with issues relating to their diagnosis an management, complications of their cancer, complications arising from their treatment, or who require appropriate symptom control or palliative care. Recent years have seen substantial service development to ensure acute oncology is appropriately provided, to improve outcomes and wellbeing of patients.A team of experts in cancer care have completely revised and updated the previous edition of this book to produce a template that can be used by any professional involved in the planning and delivery of acute oncology care around the world.This title is formally supported by the Association of Cancer Physicians (ACP). This highly patient-centred, readable text will be of value to clinicians and healthcare professionals, healthcare strategic and operations managers, and doctors in training, in their daily work.

There have been impressive improvements in the diagnosis and treatment of cancer in recent decades. In economically advantaged countries with well-developed healthcare systems over 50% of all cancer patients achieve long term survival and are probably cured. Not only has survival improved radically for cancer patients but also there has been an increasing focus on the quality of patient's lives, on improving the patient experience of care and on developing effective support for the very many cancer survivors. Despite the progress in cancer treatment, unfortunately a substantial number of cancer patients will still ultimately die of their disease. For many this will follow periods of successful treatment which results in good remissions and good quality of life. Helping patients to make the right choices about their care towards the end of their lives is one of the greatest and most challenging responsibilities of all healthcare professionals.Legal change on the provision of assisted dying by healthcare professionals has occurred in a substantial number of jurisdictions. This work brings together contributions on end of life choices from experienced professionals from oncology disciplines, palliative care, law, nurses and professions allied to medicine. The goals are:*To better inform cancer care professionals and the wider community about developments in choices in end of life care for cancer patients internationally. *To better answer questions from patients and respond to requests from patients, including questions about and requests for assisted dying in countries where it is legal to do so. *To have a balanced and well informed dialogue about choices available to patients without developing a formal policy position on change in law.*To provide a basis of information for future educational activities.

The treatment of cancer in young women and men is increasingly turning from focusing purely on survival to a recognition of the long-term effects of treatment on subsequent quality of life. In this regard, fertility is a very high priority for patients. This is the first book to explain the latest techniques in fertility preservation. Chapters cover fertility preservation in both women and men, management of cancer in pregnancy, egg donation and surrogacy, hormone replacement options, counselling and ethical issues. A multidisciplinary team of over 60 specialists were involved in this work, with contributions from leading obstetricians, medical oncologists, gynaecological oncologists, urologists and fertility specialists. The book is formally supported by the Association of Cancer Physicians (ACP). This highly patient-centred, readable text will be of value to a wide range of clinicians and physicians, and doctors in training, in their daily work.

*A highly illustrated guide and reference for haematologists, oncologists and clinical scientists*Guiding investigation, differential diagnosis, prognosis and treatment optionsMeeting the needs of haematologists, oncologists and clinical scientists for an up-to-date reference, this handbook provides a visual presentation of lymphoproliferative disorders, lymphoid leukaemias and plasma cell neoplasms. Each malignancy is surveyed based on molecular and cellular changes, including histochemistry, cytochemistry and relevant radiographs. Pertinent clinical information relating to clinical presentation, differential diagnosis and prognostic indicators are concisely outlined, using numerous graphics and citing key references in the field.

Interventional oncology (IO) consists of the use of image-guided minimally invasive techniques to diagnose and treat patients with cancer. Alongside medical, surgical and radiation oncology this constitutes an important approach with potential to improve cancer treatment and care.A team of experts in interventional oncology and cancer care have created a new introduction that may be used by any professional involved in the planning and delivery of interventional oncology care around the world. The text is particularly helpful and timely, and will again serve as a valuable resource for those who develop new interventional oncology services, as well as provide a source of training and an update for clinicians working in this challenging clinical area. This title is formally supported by the Association of Cancer Physicians.

Single best answers to 500+ questions covering all of the key exam topicsPerfect preparation and practice for the medical oncology SCE and a valuable tool for the FRCR (Oncology) and ESMO examsProduced in partnership with the Association of Cancer Physicians (ACP)Written by senior trainees and consultants and verified by experienced medical oncology consultants in the style of the specialty certificate exam, this collection of 500 single best answers offers an ideal preparation for success.The aim of 500 SBAs for the Medical Oncology Specialty Certificate Exam is to provide an important evidence-based resource for trainees and non-trainees in preparation for the SCE in Medical Oncology. The practice questions enable learners to assess their own knowledge and identify gaps for further learning. Single-best answer (SBA) questions are accompanied with a description of the answer that highlights important trial data, NICE/other national guidelines and resources. The question number and layout closely mirrors that of the SCE blueprint.Topics covered follow the blueprint of the exam closely, and include: Scientific basis of malignancy, Systemic anti-cancer therapy, Acute oncology, Supportive therapies and palliative care, Breast cancer, Upper GI cancer, Colorectal and anal cancer, Lung and thoracic cancer, Gynaecological cancers, Urological and germ cell cancers, Haematological cancers, Skin cancer, Sarcoma. Less common cancers (Head and neck, CNS cancers, Endocrine), Carcinoma of unknown primary, Professional skills and ethics.Make this book the last thing you use before you take the exam.

Cancer treatment has advanced remarkably, offering hope andextending life for many. But with these advances, clinicians and policymakersare increasingly faced with the complex and challenging questions surroundingend-of-life care. How can we ensure the highest quality of life for patientswith relapsed disease? What does a well-informed dialogue on assisted dyinglook like, and who should guide it?For healthcare professionals, legislators, and the widerpublic, navigating these choices requires the most current and accurateinformation. The updated edition of a previous volume End of Life Choicesfor Cancer Patients provides a crucial resource for this evolvinglandscape.Building on the 2020 edition, this book assembles amulti-professional team of contributors-experts in oncology, palliative care,law, and allied health professions. They offer a balanced, evidence-basedexploration of modern end-of-life care, focusing on patient needs,international developments, and the far-reaching implications of legislativechange.Inside, you will find:* Updated information and insights reflectingrecent parliamentary considerations on Assisted Dying in the UK.* An exploration of the multifacetedresponsibilities of healthcare professionals in guiding patients throughdifficult end-of-life decisions.* A clear distinction between the roles of medicalexpertise and social opinion in shaping public policy on assisted dying, asdefined by a 2019 expert workshop.* Context for legislative debates, equippingprofessionals and the public with the facts needed for a balanced and informeddiscussion.This is more than a book; it is an essential tool forprofessional colleagues, legislators, and concerned citizens alike, offeringclarity and support in one of the most challenging areas of modern medicine.This guide will ensure your practice, your policies, and your understanding aregrounded in the latest evidence.